Significance of diagnostic and monitoring criterion of HbA1c as compared with fasting and 2-hour plasma glucose concentration in GCS general hospital, Ahmedabad: a retrospective study

Parth Khandhedia, Karan Sharma, Ramesh Pradhan


Background: Diabetes is a chronic disorder that has reached epidemic levels. Its complications are potentially life-threatening but can be slowed by early diagnosis and treatment. Complications develop earlier in patients having more fluctuating levels of blood glucose than those having maintained levels. Early diagnosis and treatment confer more benefits than aggressive control.

Methods: As it was a retrospective study; the data was collected from available records of patients in whom all the three tests have been executed and analysed using SPSS version 26.

Results: Diabetics were 199 (53.9%) based on FPG (fasting plasma glucose); 169 (45.8%) based on 2hPG (2-hour plasma glucose) and 230 (62.3%) based on HbA1c. When diagnosed with FPG, the sensitivity and specificity of HbA1c was 89.44% and 69.41% respectively, whereas with 2hPG it was 92.89% and 63.5%. When HbA1c was compared with FPG and 2hPG, the values are affected with history of diastolic hypertension and family history of diabetics. The values correlated with that of FPG as well as 2hPG and showed linear relationship. The regression equation HbA1c (%)=3.737+0.027×FPG (mg/dl) explains 50.4% of variation and with less error when compared to 2hPG. Hence, the values of FPG can be used to predict the approximate values of HbA1c through regression.

Conclusions: Study revealed that HbA1c has a greater potential as a diagnostic test due to its high sensitivity. The levels are affected by family history and diastolic hypertension. Our study suggests that diagnosing criteria of diabetes should be HbA1c ≥7.1% instead of the current criteria of HbA1c ≥6.5% by the relationship of HbA1c with FPG.


HbA1c, Fasting plasma glucose, 2-hour plasma glucose, Diabetes

Full Text:



Alberti KGMM, Zimmet P. Epidemiology: global burden of disease-where does diabetes mellitus fit in? Nature Rev Endocrinol. 2013;9(5):258-60.

A Ramachandran, C Snehalatha. Epidemiology and basic considerations of diabetes. API textbook of medicine. 9th ed. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd; 2012: 323.

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK prospective diabetes study (UKPDS) group. Lancet. 1998;352(9131):837-53.

Bookchin RM, Gallop PM. Structure of hemoglobin AIc: nature of the N-terminal 𝛽 chain blocking group. Biochem Biophys Res Communicat. 1968;32(1):86-93.

Rahbar S, Blumenfeld O, Ranney HM. Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochem Biophys Res Communicat. 1969;36(5):838-43.

Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N E J Med. 1976;295(8):417-20.

Erratum: lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. JAMA. 1996;276(17):1409-15.

The International Expert Committee. International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabet Care. 2009;32(7):1327-34.

Tsugawa Y, Takahashi O, Meigs JB, Davis RB, Imamura F, Fukui T, et al. New diabetes diagnostic threshold of hemoglobin A(1c) and the 3-year incidence of retinopathy. Diabetes. 2012;61(12):3280-4.

Massin P, Lange C, Tichet J, et al. Hemoglobin A1c and fasting plasma glucose levels as predictors of retinopathy at 10 years: the French DESIR study. Arch Ophthalmol. 2011;129(2):188-95.

McCance DR, Hanson RL, Charles MA, Jacobsson LT, Pettitt DJ, Bennett PH, et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. Br Med J. 1994;308(6940):1323-8.

Selvin E, Ning Y, Steffes MW, Bash LD, Klein R, Wong TY, et al. Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. Diabetes. 2011;60(1):298-305.

Leiden HAV, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, et al. Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol. 2003;121(2):245-51.

Sobrin L. Longitudinal validation of hemoglobin A1c criteria for diabetes diagnosis: risk of retinopathy. Diabetes. 2012;61(12):3074-5.

Daneman D. Type 1 diabetes. Lancet 2006;367(9513):847-58.

Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20(7):1183-97.

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes. 1979;28(12):1039-57.

The International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327-34.

Herman WH, Ye W, Griffin SJ, Simmons RK, Davies MJ, Khunti K, et al. Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch study of intensive treatment in people with screen- detected diabetes in primary care (ADDITION-Europe). Diabetes Care. 2015;38(8):1449-55.

Fajans SS, Herman WH, Oral EA. Insufficient sensitivity of hemoglobin AIc determination in diagnosis or screening of early diabetic states. Metabol Clin Experiment. 2011;60(1):86-91.

Kramer CK, Araneta MRG, Barrett-Connor E. A1C and diabetes diagnosis: the Rancho Bernardo study. Diabetes Care. 2010;33(1):101-3.

Tapp RJ, Tikellis G, Wong TY, Harper CA, Zimmet PZ, Shaw JE. Longitudinal association of glucose metabolism with retinopathy: results from the Australian diabetes obesity and lifestyle (AusDiab) study. Diabetes Care. 2008;31(7):1349-54.

Ollerton RL, Playle R, Ahmed K, Dunstan FD, Luzio SD, Owens DR. Day-to-day variability of fasting plasma glucose in newly diagnosed type 2 diabetic subjects. Diabetes Care. 1999;22(3):394-8.

Jackson CA, Yudkin JS, Forrest RD. A comparison of the relationships of the glucose tolerance test and the glycated haemoglobin assay with diabetic vascular disease in the community. The Islington Diabetes Survey. Diabet Res Clin Pract. 1992;17(2):111-23.

Araneta MRG, Grandinetti A, Chang HK. A1C and diabetes diagnosis among Filipino Americans, Japanese Americans, and Native Hawaiians. Diabetes Care. 2010;33(12):2626-8.

Bao Y, Ma X, Li H, Zhou M, Hu C, Wu H, et al. Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. Br Med J. 2010;340:2249.

Carson AP, Reynolds K, Fonseca VA, Muntner P. Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes Care. 2010;33(1):95-7.

Li HY, Ma WY, Wei JN. Hemoglobin A1c for the diagnosis of diabetes: to replace or to guide oral glucose tolerance tests? J Diabet Investigat. 2012;3(3):259-65.

Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metabol. 2008;93(7):2447-53.

Tsugawa Y, Mukamal KJ, Davis RB, Taylor WC, Wee CC. Should the hemoglobin A1c diagnostic cutoff differ between blacks and whites?: a cross-sectional study. Ann Intern Med. 2012;157(3):153-9.

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(1):81-90.

Selvin E, Crainiceanu CM, Brancati FL, Coresh J. Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med. 2007;167(14):1545-51.